Te Ahumairangi Investment Management Ltd Has $1.93 Million Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Te Ahumairangi Investment Management Ltd trimmed its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 16.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 111,306 shares of the real estate investment trust's stock after selling 21,314 shares during the quarter. Te Ahumairangi Investment Management Ltd's holdings in Sabra Health Care REIT were worth $1,928,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in SBRA. Geode Capital Management LLC increased its stake in shares of Sabra Health Care REIT by 1.7% during the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust's stock worth $117,165,000 after purchasing an additional 104,533 shares during the last quarter. JPMorgan Chase & Co. increased its position in Sabra Health Care REIT by 222.4% during the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock worth $183,996,000 after buying an additional 6,819,919 shares during the last quarter. Vestcor Inc raised its stake in Sabra Health Care REIT by 62.5% in the third quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust's stock valued at $3,869,000 after buying an additional 79,956 shares during the period. Barclays PLC lifted its position in shares of Sabra Health Care REIT by 56.1% in the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock valued at $12,624,000 after buying an additional 243,895 shares during the last quarter. Finally, Franklin Resources Inc. lifted its position in shares of Sabra Health Care REIT by 12.3% in the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust's stock valued at $9,543,000 after buying an additional 57,551 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Remove Ads

Sabra Health Care REIT Stock Performance

Shares of Sabra Health Care REIT stock traded up $0.29 during trading on Thursday, reaching $17.65. The company's stock had a trading volume of 4,055,816 shares, compared to its average volume of 2,094,596. Sabra Health Care REIT, Inc. has a 52 week low of $13.31 and a 52 week high of $20.03. The firm has a market cap of $4.20 billion, a PE ratio of 33.30, a P/E/G ratio of 1.97 and a beta of 0.93. The business's 50-day moving average price is $16.88 and its 200-day moving average price is $17.66. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Equities analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 6.80%. Sabra Health Care REIT's dividend payout ratio is presently 226.42%.

Analyst Ratings Changes

SBRA has been the topic of a number of research analyst reports. JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a research note on Tuesday, January 7th. Citizens Jmp raised shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, January 7th. Mizuho reaffirmed a "neutral" rating and set a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Finally, Truist Financial upped their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.33.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.